Eliem Therapeutics News

Eliem Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(47.5%),Peter Kolchinsky(47.5%), etc.

Apr 12 18:53 ET

Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Morisset Valerie

Apr 8 17:38 ET

Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pimblett Emily

Mar 20 16:38 ET

Eliem Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(47.5%),Peter Kolchinsky(47.5%), etc.

Mar 18 16:51 ET

Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Morisset Valerie

Mar 4 11:10 ET

Eliem Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Braden M Leonard(8.5%),BML Investment Partners, L.P.(7.9%)

Feb 7 11:56 ET

Eliem Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(47.7%),Peter Kolchinsky(47.7%), etc.

Nov 17, 2023 16:30 ET

Eliem Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

Nov 13, 2023 17:13 ET

Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.

May 22, 2023 17:22 ET

Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Tate Simon

May 22, 2023 17:13 ET

Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ratcliffe Liam

May 22, 2023 17:11 ET

Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Dunn Judith

May 22, 2023 17:08 ET

Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Rosenberg Adam Joseph

May 22, 2023 17:05 ET

Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Executive Chairman Levin Andrew David

May 22, 2023 17:02 ET

Eliem Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(48.8%),Peter Kolchinsky(48.8%), etc.

Apr 10, 2023 17:01 ET

Eliem Therapeutics | 3: Initial statement of beneficial ownership of securities-Chief Accounting Officer Pimblett Emily

Mar 21, 2023 10:21 ET

Eliem Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Morisset Valerie

Mar 14, 2023 17:04 ET

Eliem Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Intermediate Capital Investments Limited(7.5%),Intermediate Capital Group plc(7.5%)

Mar 8, 2023 16:00 ET

Eliem Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Samlyn Capital, LLC(0%),Samlyn, LP(0%), etc.

Feb 14, 2023 14:22 ET

Eliem Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Braden M Leonard(7.1%),BML Investment Partners, L.P.(6.9%)

Feb 8, 2023 16:35 ET